BioTrends Research Group, Inc.
BioTrends Announces a New Syndicated Report Series, LaunchTrends(TM): Feraheme
Published in Blood Weekly, July 16th, 2009
In conjunction with yesterday's FDA approval of AMAG Pharmaceuticals' Feraheme (ferumoxytol), BioTrends Research Group, Inc. is pleased to announce LaunchTrends(TM): Feraheme, a syndicated report series that will track the trial, adoption and usage of Feraheme. Feraheme is a new IV Iron product approved to treat iron deficiency anemia in patients with Chronic Kidney Disease, both on and not on dialysis. Surveys will be fielded at one month, three months, and six months post launch. Each report consists of findings from a quantitative survey with 50 Nephrologists and qualitative interviews with a subset of the survey respondents.
BioTrends has been following Feraheme in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2009-07-16)
More Articles from Blood Weekly
- BioMed Central
Gene map aims to combat blood flukes - Autoimmune Hemolytic Anemia
Recent studies from Catholic University add new data to autoimmune hemolytic anemia - Behcet Disease
Studies from K. Becker et al add new findings in the area of Behcet disease - Bio-Matrix Scientific Group Inc.
Bio-Matrix Scientific Group Inc. Named “Stock Pick” by WallStreetCorner.com -- Hospital and University Research Demand for Bio-Matrix’s Stem Cell Bank Cited - Blood Substitutes
Study results from Colorado State University provide new insights into blood substitutes - Breast Cancer
Research conducted by S.H. Waters and co-researchers has updated our knowledge about breast cancer - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
